Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 0.8800
-0.0300 (-3.30%)
At close: Oct 9, 2026
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of €771.74 thousand as of October 9, 2026. It is the 49,694th most valuable company in the world and the 675th biggest in Germany.
Market Cap
771.74K
Enterprise Value
11.88M
Revenue
30.00K
Global Rank
Country Rank
#675 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 52.02M to 771.74K, a decrease of -98.52%. That is a compound annual growth rate of -29.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 771.74K | -2.22% |
| Dec 30, 2025 | 789.25K | -19.48% |
| Dec 30, 2024 | 980.17K | -38.24% |
| Dec 29, 2023 | 1.59M | -76.50% |
| Dec 30, 2022 | 6.75M | -17.48% |
| Dec 30, 2021 | 8.18M | -57.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 59.93B |
| Siemens Healthineers AG | 43.57B |
| Bayer Aktiengesellschaft | 43.00B |
| Fresenius SE & Co. KGaA | 23.86B |
| NanoRepro AG | 21.82M |
| aap Implantate AG | 21.56M |
| Maternus-Kliniken Aktiengesellschaft | 18.66M |
| Biofrontera AG | 18.17M |